Rare diseases have gained recognition as a public health priority and as an area of unique European added-value for Community action. Since 1999, the European Union has taken measures to fight against rare diseases and their impact on patients’ lives, and has made rare diseases a priority of its public health programmes.
The adoption of a Council Recommendation on a European Action in the field of Rare Diseases in 2009 demonstrated the vital importance of EU action and cooperation between Member States. The two levels, European and national, are key factors of success in this area and correspond to a real need in the patient population.
"Expertise on rare diseases is fragmented across the EU. Even the very existence of some of these diseases is not fully recognised. This is an area where the added value...
Today, more than half of new national policies, laws and regulations stem from EU policies, directives and regulations. Since Eurordis represents rare disease patients from all...
EURORDIS welcomes final adoption of recommendations proposed by the council on June 9th, 2009 concerning European action in the rare disease field.
Organ donation and transplantation (ODT) is back on the European political agenda.
Promoting rare diseases as a public health priority is one of the most important stated objectives to EURORDIS.
Advocating for increased and more targeted funding for research into rare diseases
An unprecedented number of participants attended the largest ever European Conference on Rare Diseases (ECRD), held in Krakow, Poland on May 14 & 15, 2010.
An unprecedented number of 600 participants attended the largest ever European Conference on Rare Diseases